[
    [
        {
            "time": "2021-06-24",
            "original_text": "医药行业重大事项点评：第五批国采拟中标结果产生 注射剂集采大幅提速",
            "features": {
                "keywords": [
                    "第五批国采",
                    "注射剂",
                    "集采",
                    "中标"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业重大事项点评：第五批国采拟中标结果产生 注射剂集采大幅提速",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "人民金融·创新药指数涨1.32% | 6月创新药集中获批上市，今年半年获批的创新药数量已接近去年全年水平",
            "features": {
                "keywords": [
                    "创新药指数",
                    "涨1.32%",
                    "获批",
                    "上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "人民金融·创新药指数涨1.32% | 6月创新药集中获批上市，今年半年获批的创新药数量已接近去年全年水平",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "复星医药(600196)：CAR-T首家上市 先发优势望奠定龙头地位",
            "features": {
                "keywords": [
                    "复星医药",
                    "CAR-T",
                    "上市",
                    "先发优势",
                    "龙头地位"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196)：CAR-T首家上市 先发优势望奠定龙头地位",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "浙商证券维持复星医药买入评级，复星医药事件点评：CAR-T首家上市，先发优势有望奠定龙头地位",
            "features": {
                "keywords": [
                    "浙商证券",
                    "复星医药",
                    "买入评级",
                    "CAR-T",
                    "先发优势"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券维持复星医药买入评级，复星医药事件点评：CAR-T首家上市，先发优势有望奠定龙头地位",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "中泰证券给予复星医药买入评级，首个国产CAR-T获批，开启细胞治疗商业化元年",
            "features": {
                "keywords": [
                    "中泰证券",
                    "复星医药",
                    "买入评级",
                    "CAR-T",
                    "细胞治疗",
                    "商业化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券给予复星医药买入评级，首个国产CAR-T获批，开启细胞治疗商业化元年",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "开盘：恒指高开0.17%，医药股再度上扬，港股复星医药涨超1%",
            "features": {
                "keywords": [
                    "恒指",
                    "高开0.17%",
                    "医药股",
                    "复星医药",
                    "涨超1%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "开盘：恒指高开0.17%，医药股再度上扬，港股复星医药涨超1%",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "A股融资融券日报：两融余额增加57.06亿元（6月23日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "增加57.06亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "市场资金"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加57.06亿元（6月23日）",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "智通港股早知道|(6月24日) 第五批国家药品集采平均降价56%，小鹏汽车通过港交所上市聆讯",
            "features": {
                "keywords": [
                    "第五批国家药品集采",
                    "平均降价56%",
                    "小鹏汽车",
                    "上市聆讯"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智通港股早知道|(6月24日) 第五批国家药品集采平均降价56%，小鹏汽车通过港交所上市聆讯",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]